Institutes · Corporate Affiliated Research Institute
Corporate Affiliated Research Institute(KOITA No. 2021116297)
AriBnC's Corporate Affiliated Research Institute was recognised by the Korea Industrial Technology Association (KOITA) in December 2021. It has two sites — the Yongin head office (principal site) and the UNIST Research Institute in Ulsan (secondary site) — where its research is carried out. Everything from study design to the assembly of regulatory documents stays inside one organisation.
What the institute does
Design, biostatistics and the EDC sit in one team, and the same team prepares the regulatory dossier.
The institute is the team that actually runs the studies AriBnC is contracted for. It writes protocols for health functional food human studies, drug trials, medical-device trials and nonclinical work, prepares the statistical analysis plan, builds and operates the EDC in-house, and designs the CRF. The outputs are monitoring records, datasets and study reports. Measured against the development stages — nonclinical (in vitro activity, in vivo mechanism, safety review, specification, marker compound, manufacturing process and analytical method), clinical (running human studies and trials), regulatory (preparing the MFDS submission and answering deficiencies) — the institute carries the research execution.
The Corporate Affiliated Research Institute is recognised under statute
The governing act, its definition, and AriBnC's recognition.
| Item | Detail |
|---|---|
| Governing act | Act on Support for R&D by Corporate Research Institutes, etc. (Act No. 20727, enacted 31 Jan 2025, in force 1 Feb 2026; latest amendment Act No. 21309, promulgated 31 Dec 2025) |
| Definition in the act | Article 2, subparagraph 1 — a research body established and operated by a company to carry out research and development, and recognised under Article 7. Article 2, subparagraph 2 separately defines a dedicated R&D department. |
| AriBnC's recognition | Corporate Affiliated Research Institute recognition No. 2021116297 (Dec 2021), verifiable through the public lookup run by the Korea Industrial Technology Association (KOITA). |
| Relationship to the R&D Institute | They are separate. The Corporate Affiliated Research Institute is the research institute recognised under the act above; the R&D Institute is a separate organisation that develops ingredients and products on the company's own research budget. The UNIST Research Institute is its secondary site; ABCI is a separate organisation. |
The statute and its transitional provisions are published at law.go.kr.
Research areas
Two main areas; on a full-service engagement a single ingredient passes through both.
Study design and biostatistics
Protocol design and statistical analysis plans for health functional food human studies, drug trials and medical-device trials, together with monitoring, data management and study reports — all carried out at the Yongin site. In development-stage terms this is the clinical stage.
CRO servicesFunctional ingredientsIngredient development research
From bioactivity screening through mechanism, specification / marker compound / manufacturing process / analytical method, to safety review, handled as one continuous path; where it continues into dossier preparation it becomes a full-service scope running from nonclinical through to the regulatory stage.
BCS-001FWhere the institute sits, and its recognition
The Corporate Affiliated Research Institute has two sites: the Yongin head office (principal site) and the UNIST Research Institute (secondary site). The head office opened in September 2021 and was recognised as a Corporate Affiliated Research Institute in December 2021. Study design, biostatistics, EDC build and operation, CRF design and functional-ingredient research are carried out at Yongin; probiotic strain research is carried out at the UNIST Research Institute, opened in June 2024.
The AI-Bio Convergence Institute (ABCI) is a separate, independent organisation.
- Yongin head office and laboratory — Yongin-si, Gyeonggi-do, opened September 2021
- Recognised as a Corporate Affiliated Research Institute — December 2021, KOITA No. 2021116297
The recognition can be verified directly in KOITA's registry of corporate research institutes and R&D departments using recognition number 2021116297.
Tell us the ingredient, the type of study and the target market, and we will come back with whether we can run it, which site would handle it (Yongin or UNIST), and which development stage it falls under — nonclinical, clinical or regulatory.